Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Trauma/Emergency Medicine | Cardiology/Vascular Diseases
Disease Category: Surgery
Trial Information
Evaluate a novel compound in subjects with Occluded Central Venous Access Devices.
Objective is to evaluate the safety of study drug by monitoring
of adverse events and major bleeding events for up to 120 minutes
following its instillation of final dose.
Several Study Inclusion Criteria Include:
- Unable to withdraw 3 mL of blood from a central venous access
device.
- Hemodynamically stable
Several Study Exclusion Criteria Include:
- Inability to infuse at least 2 mL of saline through
catheter
- In the opinion of investigator, subject is at "high
risk" for bleeding events or embolic complications.
Holy Cross Hospital Research Center
4875 N. Federal Hwy, Suite 700
Fort Lauderdale, FL 33308
Phone: 954-229-8400
Fax: 954-229-8597
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
